Old Web
English
Sign In
Acemap
>
authorDetail
>
Daniel Di Carlo
Daniel Di Carlo
Technische Universität München
Medicine
Biodistribution
Nuclear medicine
Ligand
LNCaP
6
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Novel [F-18]siPSMA-14 shows favourable kinetics and high interobserver agreement in staging of prostate cancer patients
2021
The Journal of Nuclear Medicine
Jonathan Miksch
Vikas Prasad
Daniel Di Carlo
Anna-Sophie Strauss
Michael Grunert
Jochen Steinacker
Wolfgang M. Thaiss
Christoph Solbach
Christian Bolenz
Meinrad Beer
Thomas Wiegel
Hans Wester
Matthias Eiber
Ambros J. Beer
Show All
Source
Cite
Save
Citations (1)
Comparison of Quantification of Target-Specific Accumulation of [18F]F-siPSMA-14 in the HET-CAM Model and in Mice Using PET/MRI.
2021
Cancers
J Löffler
Carmen Hamp
Ellen Scheidhauer
Daniel Di Carlo
Christoph Solbach
Alireza Abaei
Li Hao
Gerhard Glatting
Ambros J. Beer
Volker Rasche
Gordon Winter
Show All
Source
Cite
Save
Citations (0)
Preclinical comparison of four [18F, natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics.
2020
EJNMMI research
Alexander Wurzer
Mara Parzinger
Matthias Konrad
Roswitha Beck
Thomas Günther
Veronika Felber
Stefanie Felicitas Färber
Daniel Di Carlo
Hans-Jürgen Wester
Show All
Source
Cite
Save
Citations (8)
PSMA-targeted18F-labeled Radiohybrid Inhibitors: Concept, preclinical evaluation and first proof of concept study in men
2019
The Journal of Nuclear Medicine
Alexander Wurzer
Daniel Di Carlo
Alexander Schmidt
Roswitha Beck
Matthias Eiber
Markus Schwaiger
Hans Wester
Show All
Source
Cite
Save
Citations (1)
1